Back

Base editing of cardiomyopathy-associated RBM20 p.P638L mutation

17 April 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: From drugs to genes: toxicity and therapy Gene Therapy, Cell Therapy Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Mrs Joline Gross

Heart and Diabetes Center NRW, Bad Oeynhausen (Germany)

4 More presentations in this session

Presentation thumbnail
Cardioprotective effects of small-molecule ErbB4 activation are sex-specific and oestrogen dependent
Miss B. Goovaerts (Antwerp, BE)
Abstract
Presentation thumbnail
Modeling patient-specific doxorubicin cardiotoxicity in multicellular hiPSC-derived 3D cardiac microtissues
Doctor G. Campostrini (Leiden, NL)
Abstract
Presentation thumbnail
Cardiac organoids: novel regenerative therapy for myocardial infarction
Mrs M. Kalil (Badalona, ES)
Abstract
Presentation thumbnail
Developing a model to study iPSC-CM integration with human heart tissue
Doctor D. Hayman (London, GB)
Abstract

Access the full session

Session thumbnail
From drugs to genes: toxicity and therapy

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

17 April - 19 April 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources